Company Overview - Nyxoah is introducing an innovative next-generation neuromodulation solution specifically targeting moderate-to-severe obstructive sleep apnea (OSA) patients through hypoglossal nerve stimulation [1] - The technology is characterized by bilateral stimulation and a single-incision implant, which differentiates it from existing solutions [1] Product Features - The system is designed to be fully compatible with body MRI from the outset, eliminating the need for an implantable battery [2] - The wearable component, which patients use during sleep, contains the battery and software, thus avoiding the need for resurgery when the battery is depleted [2]